Page last updated: 2024-08-26

tarenflurbil and Cognition Disorders

tarenflurbil has been researched along with Cognition Disorders in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amato, DA; Beelen, AP; Green, RC; Schneider, LS; Swabb, EA; Wilcock, G; Zavitz, KH	1

Trials

1 trial(s) available for tarenflurbil and Cognition Disorders

Article	Year
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA, 2009, Dec-16, Volume: 302, Issue:23 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Cognition; Cognition Disorders; Double-Blind Method; Enzyme Inhibitors; Female; Flurbiprofen; Humans; Male; Middle Aged; Peptide Fragments	2009

Article

Year

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.

JAMA, 2009, Dec-16, Volume: 302, Issue:23

Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Cognition; Cognition Disorders; Double-Blind Method; Enzyme Inhibitors; Female; Flurbiprofen; Humans; Male; Middle Aged; Peptide Fragments

2009

Other Studies

1 other study(ies) available for tarenflurbil and Cognition Disorders

Article	Year
Disease-modifying drug fails in Alzheimer's study. The Harvard mental health letter, 2010, Volume: 26, Issue:10 Topics: Activities of Daily Living; Alzheimer Disease; Amyloid Precursor Protein Secretases; Cognition; Cognition Disorders; Flurbiprofen; Humans; Randomized Controlled Trials as Topic; Treatment Failure; Treatment Outcome	2010